HEALTHY LYF: EPIC Asia Study about COPD

New Survey Reveals Heavy Burden of COPD and COPD Lung Attacks in Asia, including Philippines

• 1 of 4 of those with COPD symptoms in surveyed countries remain undiagnosed

• COPD poses a heavy burden burden in Asia, particularly in the Philippines: Among the Filipino respondents, 62% were unable to work, and 70% of those able to work full-time or part on average miss 14 days at work

• Majority of sufferers worry about COPD lung attacks affecting their quality of life

• Once daily tablet, roflumilast, a first-in-class treatment is launched to target the underlying cause of COPD and reduce risk of COPD lung attacks

COPD is a debilitating disease which poses a significant burden in Asia. Key findings from the new landmark “Epidemiology and Impact of COPD in Asia” Survey  (EPIC Asia Survey) show that COPD affects the quality of life and impacts work productivity. Yet the disease is still largely underdiagnosed and sub-optimally treated with almost half of those surveyed with COPD symptoms still undiagnosed.